A James Mason

24PUBLICATIONS
28CO-AUTHORS
Basic pharmacologyNanomaterialsBiologically active moleculesMedical infection agents (incl. prions)Biomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 28, 2026
Enantiomer-dependent biodistribution and exposure determine the in vivo behavior of a pleurocidin-derived antimicrobial peptide.

|Jun 22, 2026
Tyrosine-capped gold nanoparticles enable cysteine-free peptide loading, enhancing the antipseudomonal efficacy of scorpion-derived AamAP1-Lys-NH2 in a burn wound infection model.

|May 29, 2026
Light-controlled inhibition of Gram-positive bacteria by photoswitchable amphiphilic lipids (PALs).

|Jun 18, 2025
Enhanced Gram-Negative Membrane Disruption and In Vivo Efficacy via Lysine-Arginine Enrichment of Opis16a.

Mandelie van der Walt, Carel B Oosthuizen, Miruna Serian

|Feb 17, 2025
Improving the Activity and Selectivity of a Scorpion-Derived Peptide, A3a, against Acinetobacter baumannii through Rational Design.

Dalton S Möller, Mandelie van der Walt, Carel Oosthuizen

|Jan 28, 2025
Carboxy-Amidated AamAP1-Lys has Superior Conformational Flexibility and Accelerated Killing of Gram-Negative Bacteria.

Rosalind J Van Wyk, June C Serem, Carel B Oosthuizen

Pageof 4

Frequent Collaborators

9 joint publications

Christian D Lorenz

6 joint publications

Maria Clarke

5 joint publications

Anabella R M Gaspar

5 joint publications

J Mark Sutton